Associations of CTCF and FOXA1 with androgen and IGF pathways in men with localized prostate cancer

被引:1
作者
Barker, Rachel [1 ]
Biernacka, Kalina [1 ]
Kingshott, Georgina [1 ]
Sewell, Alex [2 ]
Gwiti, Paida [2 ,3 ]
Martin, Richard M. [4 ,5 ,6 ]
Lane, J. Athene [7 ]
McGeagh, Lucy [8 ]
Koupparis, Anthony [9 ]
Rowe, Edward [9 ]
Oxley, Jon [2 ]
Perks, Claire M. [1 ]
Holly, Jeff M. P. [1 ]
机构
[1] Southmead Hosp, Bristol Med Sch, IGF & Metab Endocrinol Grp, Translat Hlth Sci, Learning & Res Bldg, Bristol BS10 5NB, England
[2] Southmead Hosp, Dept Cellular Pathol, North Bristol NHS Trust, Bristol BS10 5NB, England
[3] North West Anglia NHS Fdn Trust, Dept Pathol, Peterborough PE3 2PS, England
[4] Univ Bristol, Bristol Med Sch, Populat Hlth Sci, 39 Whatley Rd,Canynge Hall, Bristol BS8 2PS, England
[5] Univ Hosp Bristol, Biomed Res Ctr, Natl Inst Hlth Res, Lower Maudlin St, Bristol BS1 2LY, England
[6] Weston NHS Fdn Trust & Univ Bristol, Univ Hosp Bristol Educ Ctr, Dent Hosp, Biomed Res Unit Off, Lower Maudlin St, Bristol BS1 2LY, England
[7] Univ Bristol, Bristol Trials Ctr, Bristol Med Sch, Populat Hlth Sci, 39 Whatley Rd,Canynge Hall, Bristol BS8 2PS, England
[8] Oxford Brookes Univ, Oxford Inst Nursing, Fac Hlth & Life Sci, Support Canc Care Res Grp,Midwifery & Allied Hlth, Jack Straws Lane, Oxford OX3 0FL, England
[9] Southmead Hosp, Bristol Urol Inst, Dept Urol, Bristol BS10 5NB, England
基金
英国医学研究理事会;
关键词
IGF; CTCF; FOXA1; Prostate cancer; Androgen signaling; FORKHEAD BOX A1; RECEPTOR-BINDING; RISK VARIANTS; EXPRESSION; REVEALS; BREAST; MASTER; H19;
D O I
10.1016/j.ghir.2023.101533
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Aims: To examine associations between the transcription factors CCCTC-binding factor (CTCF) and forkhead box protein A1 (FOXA1) and the androgen receptor (AR) and their association with components of the insulin-like growth factor (IGF)-pathway in a cohort of men with localized prostate cancer.Methods: Using prostate tissue samples collected during the Prostate cancer: Evidence of Exercise and Nutrition Trial (PrEvENT) trial (N = 70 to 92, depending on section availability), we assessed the abundance of CTCF, FOXA1, AR, IGFIR, p-mTOR, PTEN and IGFBP-2 proteins using a modified version of the Allred scoring system. Validation studies were performed using large, publicly available datasets (TCGA) (N = 489).Results: We identified a strong correlation between CTCF and AR staining with benign prostate tissue. CTCF also strongly associated with the IGF-IR, with PTEN and with phospho-mTOR. FOXA1 was also correlated with staining for the IGF-IR, with IGFBP-2 and with staining for activated phosphor-mTOR. The staining for the IGF-IR was strongly correlated with the AR.Conclusion: Our findings emphasise the close and complex links between the endocrine controls, well known to play an important role in prostate cancer, and the transcription factors implicated by the recent genetic evidence.
引用
收藏
页数:7
相关论文
共 50 条
  • [41] BASELINE SERUM TESTOSTERONE IN MEN TREATED WITH ANDROGEN DEPRIVATION THERAPY AND RADIOTHERAPY FOR LOCALIZED PROSTATE CANCER
    Roach, Mack, III
    Bae, Kyounghwa
    Lawton, Colleen
    Donnelly, B. J.
    Grignon, David
    Hanks, Gerald E.
    Porter, Arthur
    Lepor, Herbert
    Venketesan, Varagur
    Sandler, Howard
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2010, 78 (05): : 1314 - 1322
  • [42] Opposite roles of FOXA1 and NKX2-1 in lung cancer progression
    Deutsch, Lena
    Wrage, Michaela
    Koops, Susann
    Glatzel, Markus
    Uzunoglu, Faik G.
    Kutup, Asad
    Hinsch, Andrea
    Sauter, Guido
    Izbicki, Jakob R.
    Pantel, Klaus
    Wikman, Harriet
    GENES CHROMOSOMES & CANCER, 2012, 51 (06) : 618 - 629
  • [43] Obesity and prostate enlargement in men with localized prostate cancer
    Kopp, Ryan P.
    Han, Misop
    Partin, Alan W.
    Humphreys, Elizabeth
    Freedland, Stephen J.
    Parsons, J. Kellogg
    BJU INTERNATIONAL, 2011, 108 (11) : 1750 - 1755
  • [44] The transcription factor FOXA1 induces epithelial ovarian cancer tumorigenesis and progression
    Wang, Li-Li
    Xiu, Yin-Ling
    Chen, Xi
    Sun, Kai-Xuan
    Chen, Shuo
    Wu, Dan-Dan
    Liu, Bo-Liang
    Zhao, Yang
    TUMOR BIOLOGY, 2017, 39 (05)
  • [45] Association of Genetic Polymorphisms in FOXA1 with the Progression of Genetic Susceptibility to Gastric Cancer
    Ding, Guo-wen
    Gu, Xu-yu
    Dai, Zhe
    Pan, Hui-wen
    Wang, Xiao-yan
    Zhang, Heng
    Fan, Yu
    GASTROENTEROLOGY RESEARCH AND PRACTICE, 2020, 2020
  • [46] Safety of androgen therapy in men with prostate cancer
    Rajan, Prabhakar
    Tharakan, Tharu
    Chen, Runzhi
    BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM, 2022, 36 (05)
  • [47] Androgen receptor and FOXA1 coexpression define a "luminal-AR" subtype of feline mammary carcinomas, spontaneous models of breast cancer
    Dagher, Elie
    Royer, Violette
    Buchet, Paul
    Abadie, Jerome
    Loussouarn, Delphine
    Campone, Mario
    Nguyen, Frederique
    BMC CANCER, 2019, 19 (01)
  • [48] FOXA1 in Breast Cancer: A Luminal Marker with Promising Prognostic and Predictive Impact
    Metovic, Jasna
    Borella, Fulvio
    D'Alonzo, Marta
    Biglia, Nicoletta
    Mangherini, Luca
    Tampieri, Cristian
    Bertero, Luca
    Cassoni, Paola
    Castellano, Isabella
    CANCERS, 2022, 14 (19)
  • [49] Should Tumor Infiltrating Lymphocytes, Androgen Receptor, and FOXA1 Expression Predict the Clinical Outcome in Triple Negative Breast Cancer Patients?
    Mangia, Anita
    Saponaro, Concetta
    Vagheggini, Alessandro
    Opinto, Giuseppina
    Centonze, Matteo
    Vicenti, Chiara
    Popescu, Ondina
    Pastena, Maria
    Giotta, Francesco
    Silvestris, Nicola
    CANCERS, 2019, 11 (09)
  • [50] Hyperglycemia and prostate cancer recurrence in men treated for localized prostate cancer
    Wright, J. L.
    Plymate, S. R.
    Porter, M. P.
    Gore, J. L.
    Lin, D. W.
    Hu, E.
    Zeliadt, S. B.
    PROSTATE CANCER AND PROSTATIC DISEASES, 2013, 16 (02) : 204 - 208